358 related articles for article (PubMed ID: 36394631)
41. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
42. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
Torlakovic EE; Aamot HV; Heim S
J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
[TBL] [Abstract][Full Text] [Related]
43. Two for One: B-Cell Lymphomas with Features of Marginal and Follicular Lymphomas.
Glazyrin A; Patel C; Kujtan L; Madhusudhana S
Acta Haematol; 2018; 139(2):84-88. PubMed ID: 29408811
[TBL] [Abstract][Full Text] [Related]
44. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract][Full Text] [Related]
45. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
46. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
[TBL] [Abstract][Full Text] [Related]
47. Canine indolent nodular lymphoma.
Valli VE; Vernau W; de Lorimier LP; Graham PS; Moore PF
Vet Pathol; 2006 May; 43(3):241-56. PubMed ID: 16672571
[TBL] [Abstract][Full Text] [Related]
48. Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma.
Tari A; Asaoku H; Kunihiro M; Tanaka S; Fujihara M; Yoshino T
Digestion; 2011; 83(3):191-7. PubMed ID: 21266815
[TBL] [Abstract][Full Text] [Related]
49. [Chronic lymphoproliferative disorders].
Salles G
Rev Prat; 2002 May; 52(9):966-71. PubMed ID: 12063762
[TBL] [Abstract][Full Text] [Related]
50. Marginal zone B-cell lymphomas.
Sagaert X; Tousseyn T
Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
[TBL] [Abstract][Full Text] [Related]
51. Primary cutaneous B-cell lymphoma: narrative review of the literature.
Grandi V; Alberti Violetti S; La Selva R; Cicchelli S; Delfino C; Fava P; Fierro MT; Pileri A; Pimpinelli N; Quaglino P; Berti E
G Ital Dermatol Venereol; 2019 Aug; 154(4):466-479. PubMed ID: 29144099
[TBL] [Abstract][Full Text] [Related]
52. Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.
Krijgsman O; Gonzalez P; Ponz OB; Roemer MG; Slot S; Broeks A; Braaf L; Kerkhoven RM; Bot F; van Groningen K; Beijert M; Ylstra B; de Jong D
Haematologica; 2013 Dec; 98(12):1921-9. PubMed ID: 23850804
[TBL] [Abstract][Full Text] [Related]
53. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
[TBL] [Abstract][Full Text] [Related]
54. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
56. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
57. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
Magro CM; Kalomeris T; Roberts A
Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
[TBL] [Abstract][Full Text] [Related]
58. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
59. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract][Full Text] [Related]
60. Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
Lasica M; Anderson MA; Boussioutas A; Gregory GP; Hamad N; Manos K; McKelvie P; Ng M; Campbell B; Palfreyman E; Salvaris R; Weinkove R; Wight J; Opat S; Tam C
Intern Med J; 2024 Jun; 54(6):1017-1030. PubMed ID: 38881453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
